Clinical Trials Directory

Trials / Conditions / MSI-H Cancer

MSI-H Cancer

8 registered clinical trials studyying MSI-H Cancer — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAssessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822
Peking UniversityPhase 2
RecruitingStudy of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT06974110
MOMA TherapeuticsPhase 1
RecruitingA Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
NCT06898450
Nimbus Wadjet, Inc.Phase 1 / Phase 2
RecruitingOpen Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors
NCT05483400
University Medical Center GroningenPhase 2
CompletedVascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside
NCT06020651
Institut Mutualiste MontsourisN/A
Active Not RecruitingStudy of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
NCT05651022
Indaptus Therapeutics, IncPhase 1 / Phase 2
Active Not RecruitingA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
NCT05199272
23andMe, Inc.Phase 1 / Phase 2
RecruitingA Beta-only IL-2 ImmunoTherapY Study
NCT05086692
Medicenna Therapeutics, Inc.Phase 1 / Phase 2